| Literature DB >> 15293085 |
Abstract
In the face of a global epidemic of HIV/AIDS with the majority of individuals living in the developing countries, a protective vaccine seem the foremost goal. As this is not within imminent reach, the other option would be immunotherapy that prolongs the asymptomatic phase of infection. The basis for such a therapy is to understand the correlates of protective immunity against HIV. Here we present the most recent advances regarding selected parts of the immune response towards HIV.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15293085 DOI： 10.1007/s15010-004-6404-7
Source DB: PubMed Journal: Infection ISSN： 0300-8126 Impact factor: 3.553